List of SBIR/STTR awards granted to Cytocybernetics Inc
Name | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
A SBIR Phase I contract was awarded to Cytocybernetics Inc in July, 2020 for $250,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43HL150989-01A1 | Phase I | 250,000 | July 9, 2020 | |||||||
A STTR Phase II contract was awarded to Cytocybernetics Inc in January, 2018 for $1,484,019.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | STTR | 2R42HL127901-02A1 | Phase II | 1,484,019 | January 1, 2018 | |||||||
A SBIR Phase I contract was awarded to Cytocybernetics Inc in September, 2018 for $249,953.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43MH119842-01A1 | Phase I | 249,953 | September 19, 2018 | |||||||
A SBIR Phase II contract was awarded to Cytocybernetics Inc in March, 2022 for $860,834.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 2R44MH119842-02A1 | Phase II | 860,834 | March 1, 2022 | |||||||
A SBIR Phase I contract was awarded to Cytocybernetics Inc in July, 2022 for $256,581.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43NS125749-01 | Phase I | 256,581 | July 15, 2022 | |||||||
A SBIR Phase II contract was awarded to Cytocybernetics Inc in March, 2022 for $1,000,000.0 USD from the National Science Foundation. | SBIR | 2151522 | Phase II | 1,000,000 | March 1, 2022 | |||||||
A STTR Phase I contract was awarded to Cytocybernetics Inc in July, 2015 for $241,933.0 USD from the U.S. Department of Health & Human Services. | STTR | 1R41HL127901-01A1 | Phase I | 241,933 | July 1, 2015 | |||||||
A STTR Phase I contract was awarded to Cytocybernetics Inc in July, 2019 for $225,000.0 USD from the National Science Foundation. | STTR | 1913793 | Phase I | 225,000 | July 1, 2019 |
